BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1416 related articles for article (PubMed ID: 33956882)

  • 1. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis.
    Musuuza JS; Watson L; Parmasad V; Putman-Buehler N; Christensen L; Safdar N
    PLoS One; 2021; 16(5):e0251170. PubMed ID: 33956882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
    Garcia-Vidal C; Sanjuan G; Moreno-García E; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Fernandez-Pittol M; Pitart C; Inciarte A; Bodro M; Morata L; Ambrosioni J; Grafia I; Meira F; Macaya I; Cardozo C; Casals C; Tellez A; Castro P; Marco F; García F; Mensa J; Martínez JA; Soriano A;
    Clin Microbiol Infect; 2021 Jan; 27(1):83-88. PubMed ID: 32745596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV-2 infection than negative patients and are associated to a worse outcome.
    De Francesco MA; Signorini L; Piva S; Pellizzeri S; Fumarola B; Corbellini S; Piccinelli G; Simonetti F; Carta V; Mangeri L; Padovani M; Vecchiati D; Latronico N; Castelli F; Caruso A
    J Med Virol; 2023 Jul; 95(7):e28892. PubMed ID: 37394790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What happened during COVID-19 in African ICUs? An observational study of pulmonary co-infections, superinfections, and mortality in Morocco.
    Aissaoui Y; Ennassimi Y; Myatt I; El Bouhiaoui M; Nabil M; Bahi M; Arsalane L; Miloudi M; Belhadj A
    PLoS One; 2022; 17(12):e0278175. PubMed ID: 36454978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial/fungal infection in hospitalized patients with COVID-19 in a tertiary hospital in the Community of Castilla y León, Spain.
    Nebreda-Mayoral T; Miguel-Gómez MA; March-Rosselló GA; Puente-Fuertes L; Cantón-Benito E; Martínez-García AM; Muñoz-Martín AB; Orduña-Domingo A
    Enferm Infecc Microbiol Clin (Engl Ed); 2022 Apr; 40(4):158-165. PubMed ID: 35216948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study.
    Falcone M; Tiseo G; Giordano C; Leonildi A; Menichini M; Vecchione A; Pistello M; Guarracino F; Ghiadoni L; Forfori F; Barnini S; Menichetti F;
    J Antimicrob Chemother; 2021 Mar; 76(4):1078-1084. PubMed ID: 33374002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of co-infections and secondary infections in patients with COVID-19.
    Feldman C; Anderson R
    Pneumonia (Nathan); 2021 Apr; 13(1):5. PubMed ID: 33894790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-acquired viral respiratory infections amongst hospitalized inpatients during a COVID-19 outbreak in Singapore: co-infection and clinical outcomes.
    Wee LE; Ko KKK; Ho WQ; Kwek GTC; Tan TT; Wijaya L
    J Clin Virol; 2020 Jul; 128():104436. PubMed ID: 32447256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory co-and superinfections in COVID-19.
    Del Pozo JL
    Rev Esp Quimioter; 2021 Sep; 34 Suppl 1(Suppl1):69-71. PubMed ID: 34598432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients.
    Buehler PK; Zinkernagel AS; Hofmaenner DA; Wendel Garcia PD; Acevedo CT; Gómez-Mejia A; Mairpady Shambat S; Andreoni F; Maibach MA; Bartussek J; Hilty MP; Frey PM; Schuepbach RA; Brugger SD
    Cell Rep Med; 2021 Apr; 2(4):100229. PubMed ID: 33748789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza co-infection associated with severity and mortality in COVID-19 patients.
    Alosaimi B; Naeem A; Hamed ME; Alkadi HS; Alanazi T; Al Rehily SS; Almutairi AZ; Zafar A
    Virol J; 2021 Jun; 18(1):127. PubMed ID: 34127006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and associated outcomes of coinfection between SARS-CoV-2 and influenza: a systematic review and meta-analysis.
    Yan X; Li K; Lei Z; Luo J; Wang Q; Wei S
    Int J Infect Dis; 2023 Nov; 136():29-36. PubMed ID: 37648094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of early- and late-onset bacterial, viral, and fungal respiratory superinfections in invasively ventilated COVID-19 patients.
    Paparoupa M; Aldemyati R; Roggenkamp H; Berinson B; Nörz D; Olearo F; Kluge S; Roedl K; de Heer G; Wichmann D
    J Med Virol; 2022 May; 94(5):1920-1925. PubMed ID: 34951498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, risk factors, and outcomes of secondary infections among hospitalized patients with COVID-19 or post-COVID-19 conditions in Victoria, 2020-2023.
    Murray HC; Muleme M; Cooper D; McNamara BJ; Hussain MA; Bartolo C; O'Brien DP; Athan E
    Int J Infect Dis; 2024 Aug; 145():107078. PubMed ID: 38697606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory viral co-infections in patients with COVID-19 and associated outcomes: A systematic review and meta-analysis.
    Krumbein H; Kümmel LS; Fragkou PC; Thölken C; Hünerbein BL; Reiter R; Papathanasiou KA; Renz H; Skevaki C
    Rev Med Virol; 2023 Jan; 33(1):e2365. PubMed ID: 35686619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Worldwide prevalence of microbial agents' coinfection among COVID-19 patients: A comprehensive updated systematic review and meta-analysis.
    Pakzad R; Malekifar P; Shateri Z; Zandi M; Akhavan Rezayat S; Soleymani M; Karimi MR; Ahmadi SE; Shahbahrami R; Pakzad I; Abdi F; Farahani A; Soltani S; Kesheh MM; Hosseini P
    J Clin Lab Anal; 2022 Jan; 36(1):e24151. PubMed ID: 34851526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-infections in people with COVID-19: a systematic review and meta-analysis.
    Lansbury L; Lim B; Baskaran V; Lim WS
    J Infect; 2020 Aug; 81(2):266-275. PubMed ID: 32473235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of COVID-19 patients with bacterial coinfection admitted to the hospital from the emergency department in a large regional healthcare system.
    Lardaro T; Wang AZ; Bucca A; Croft A; Glober N; Holt DB; Musey PI; Peterson KD; Trigonis RA; Schaffer JT; Hunter BR
    J Med Virol; 2021 May; 93(5):2883-2889. PubMed ID: 33448423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between steroid use and superinfections in SARS-CoV-2 patients. A systematic review and meta-analysis.
    González Ramírez M; Hoyos Muñoz JA; Moreno Gómez GA; Aguirre Flórez M; Gómez González JF
    Infect Ecol Epidemiol; 2023; 13(1):2277000. PubMed ID: 38187166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 71.